rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RYTM
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out (RYTM)
      9h agoSeeking AlphaAZNRYTMLLY
      Rythm Pharmaceuticals gains on report Eli Lilly made $150/share offer with CVR
      Nov 17Seeking AlphaRYTMLLY
      Rhythm Pharmaceuticals Says Rare Obesity Drug Delivers Sustained Two-Year BMI Reductions
      Nov 17BenzingaRYTM
      Rhythm Pharmaceuticals: Bull Case Intact, But The Market Is Pricing In A Lot
      Nov 10Seeking AlphaRYTM
      Rhythm Pharmaceuticals gains on report of additional bidder (RYTM:NASDAQ)
      Nov 6Seeking AlphaRYTM
      AstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
      Nov 4ReutersRYTM
      Exclusive | AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals
      Nov 4WSJAZNRYTM
      Rhythm Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceRYTM
      Rhythm Pharmaceuticals Inc (RYTM) Q3 2026 Earnings Call Highlights: Revenue Surges 29% on ...

      Rhythm Pharmaceuticals Inc (RYTM) posted $92.1 million in Q3 2026 net product sales, driven by a robust U.S. launch in acquired HO, expanding reimbursement, and a strategic LG Chem royalty buy-down.

      Nov 4Yahoo FinanceRYTM
      Rhythm Pharmaceuticals Q3 Earnings Call Highlights
      Nov 3Yahoo FinanceRYTM
      Rhythm Pharmaceuticals president & CEO Meeker sells $5.13m stock
      Sep 15Investing.comRYTM
      Obesity Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Rhythm Pharma, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical
      Sep 10BarchartPRQRRYTM
      Rhythm Pharmaceuticals at Wells Fargo conference: ho launch gains traction
      Sep 9Investing.comRYTMWFC

      This is the newest page. Registered accounts read further back.